Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions
Condition(s):BioequivalenceLast Updated:June 6, 2019Completed
Hide Studies Not Open or Pending
Condition(s):BioequivalenceLast Updated:June 6, 2019Completed
Condition(s):Atrial FibrillationLast Updated:September 23, 2021Completed
Condition(s):Arrhythmia, CardiacLast Updated:June 12, 2017Completed
Condition(s):Supraventricular Arrhythmia; Septic ShockLast Updated:August 2, 2022Completed
Condition(s):Atrial FibrillationLast Updated:November 25, 2013Completed
Condition(s):Atrial FibrillationLast Updated:February 14, 2023Recruiting
Condition(s):Atrial FibrillationLast Updated:June 3, 2022Terminated
Condition(s):ArrhythmiaLast Updated:July 19, 2022Recruiting
Condition(s):Atrial FibrillationLast Updated:July 7, 2009Completed
Condition(s):Premature Ventricular ComplexLast Updated:June 21, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.